Spinogenix Announces Open Enrollment for Phase 2 US Trial Following FDA Clearance of IND Application for SPG302, the First Synaptic Regenerative Therapy for Schizophrenia
LOS ANGELES, March 31, 2025 /PRNewswire/ — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore... Read more.
Halozyme Announces Bristol Myers Squibb Received Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) with ENHANZE® Across Multiple Solid Tumor Indications
A decision on the European marketing authorization extension for the subcutaneous formulation of Opdivo is expected by June 2, 2025 SAN DIEGO, March 31, 2025 /PRNewswire/... Read more.
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
The U.S. Food and Drug Administration (FDA) agreed to reduce the number of patients in the NEPHRO CRRT study from 166 to 70 patients, of which 6 patients are already... Read more.
Hesai Lidar Exclusively Powers Baidu Apollo Go’s Deployment of Over 1,000 L4 Autonomous Vehicles in Dubai
PALO ALTO, Calif., March 31, 2025 /PRNewswire/ — Hesai Technology (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotics... Read more.
WERFEN COMMERCIALIZES ACL TOP® FAMILY 70 SERIES HEMOSTASIS TESTING SYSTEMS IN NORTH AMERICA
—Delivering Optimized Workflow Across the Hemostasis Laboratory Network with a Powerful Combination of Quality and Efficiency— BEDFORD, Mass., March 31, 2025... Read more.
Commvault Names Security Veteran Bill O’Connell as Chief Security Officer
TINTON FALLS, N.J., March 31, 2025 /PRNewswire/ — Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, today... Read more.
Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia
All Patients Treated with INGREZZA® (valbenazine) Capsules Reached a Therapeutic Dose from Day One, While Only Approximately Half of Patients Treated with Deutetrabenazine... Read more.
Bundy Family Dentistry Partners with Brown Bacon AI to Launch First-Ever Generative AI Patient Care Solution
OMAHA, Neb., March 31, 2025 /PRNewswire/ — Bundy Family Dentistry has teamed up with Brown Bacon AI, a leader in generative AI technology, to become the first... Read more.
NTT ExC and Vantiq Launch “YourNavi-QAI” – A GenAI-Powered HR Agent Designed to Transform the Employee Experience
New AI-native solution helps enterprises automate internal inquiries, streamline HR operations and deliver a modern employee experience TOKYO and WALNUT CREEK, Calif.,... Read more.
Siemens to establish global AI Manufacturing Technologies R&D Center for Battery Production in Canada
Investment of CAD$150 million (ca. €97 million) over five years Center supports Canada’s strategy to advance national battery and EV ecosystem HANNOVER,... Read more.